| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/19/2007 | CN101036748A Quality control method of the Yixinshu Chinese traditional medicine for supplementing qi and for promoting blood circulation by removing blood stasis |
| 09/19/2007 | CN101036731A Sanzi tea having antihypertensive function |
| 09/19/2007 | CN101036728A Selenium germanium peptide maggot skin antithrombotic jujube tea powder for curing encephalatrophy radically |
| 09/19/2007 | CN101036726A Myocardial and brain developer and its prepn |
| 09/19/2007 | CN101036708A Medicine composition for treatment of cardio-cerebralvascular disease |
| 09/19/2007 | CN101036707A Pill for easing heart and the method for preparing the same |
| 09/19/2007 | CN101036705A Buyang huanwu gantong medicine for preventing and curing cardiovascular or cerebrovascular disease and the agent and the method for preparing the same |
| 09/19/2007 | CN101036698A Mulberry leaf extract and its preparing process and application |
| 09/19/2007 | CN101036693A Chinese traditional medicine agent took orally for curing coronary heart disease and angina |
| 09/19/2007 | CN101036689A Judgment and treatment for duya liquid-hypertension |
| 09/19/2007 | CN101036688A Preparation for cardiovascular or cerebrovascular disease and the preparing method |
| 09/19/2007 | CN101036682A Method for preparing epimedium brevicornum wine |
| 09/19/2007 | CN101036675A Method for extracting flavonoids from the waxberry core |
| 09/19/2007 | CN101036663A Medicinal composition containing hydroxypropyl Zhigan and its preparing process |
| 09/19/2007 | CN101036642A Ginkgolide B nanometric liposomes medicine and the preparing method thereof |
| 09/19/2007 | CN101036641A Medical function of cnidium monnieri lactone |
| 09/19/2007 | CN101036640A Novel medical function of cnidium monnieri lactone |
| 09/19/2007 | CN101036637A Application of salvia miltiorrhiza bge I sodium sulfonate in the preparation of medicine and its medicine made by the same |
| 09/19/2007 | CN101036636A Method for increasing the oral bioavailability of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100337654C Composition of Chinese medicine effective ingredients for treating cardiovascular disease |
| 09/19/2007 | CN100337636C Medicinal composition contg. ginseng secondary glycosides, prepn. method and application thereof |
| 09/19/2007 | CN100337634C Dropping pill of pueraria flavone and its preparing process |
| 09/19/2007 | CN100337633C Rhodiola root glycosides injection for treating cardiovascular/cerebrovascular diseases and preparation method thereof |
| 09/19/2007 | CN100337629C Milrinone sodium chloride injection and production thereof |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/19/2007 | CN100337615C Oral disintegration tablet prepared from general saponin of notoginseng for treating thrombosis, and preparing technique |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271269 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271260 3,4-dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same |
| 09/18/2007 | US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action |
| 09/18/2007 | US7271196 CETP activity inhibitors |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | US7270838 Composition for treating chronic venous insufficiencies using an extract of red vine leaves |
| 09/18/2007 | US7270833 Use of potassium for production of cardioplegic solution for prevention of stone heart development during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation |
| 09/18/2007 | US7270815 2-O sulfatase compositions and related methods |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2413624C Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2259621C Isocoumarin derivatives and their use in medicines |
| 09/18/2007 | CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives |
| 09/18/2007 | CA2221991C Di- and trivalent small molecule selectin inhibitors |
| 09/18/2007 | CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/18/2007 | CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 09/13/2007 | WO2007103160A2 Stearidonic acid for improving cardiovascular health |
| 09/13/2007 | WO2007102562A1 Novel antithrombotic agent |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102439A1 Fractionation product of aqueous extract of eucommia ulmoides oliver leaf, and composition for oral ingestion comprising the fractionation product |
| 09/13/2007 | WO2007101925A1 Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament |
| 09/13/2007 | WO2007087241A3 Treatment of ischemic disease using thrombopoietin |
| 09/13/2007 | WO2007084949A3 Modulators of cardiac cell hypertrophy and hyperplasia |
| 09/13/2007 | WO2007049089A8 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues |
| 09/13/2007 | WO2007022089A3 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products |
| 09/13/2007 | WO2007002972A3 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 09/13/2007 | WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/13/2007 | US20070213800 Method and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 09/13/2007 | US20070213402 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213280 Steroidal Saponins Compound, the Process for Producing the Same and the Use Thereof |
| 09/13/2007 | US20070212423 Stem cells that transform to beating cardiomyocytes |
| 09/13/2007 | US20070212348 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | DE60124710T2 Analoge des glucagon ähnlichen peptid-1 Analogs of glucagon-like peptide-1 |
| 09/13/2007 | CA2645086A1 Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament |
| 09/13/2007 | CA2644154A1 Stearidonic acid for improving cardiovascular health |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832584A1 Pyrimidinylisoxazol derivative |
| 09/12/2007 | EP1832296A1 Composition for treating or preventing myocardial disorder or heart failure |
| 09/12/2007 | EP1832290A2 Compositions and methods for use in targeting vascular destruction |
| 09/12/2007 | EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/12/2007 | EP1832284A1 Adiponectin inducer or secretagogue |
| 09/12/2007 | EP1831211A1 Indazole-carboxamide compounds |
| 09/12/2007 | EP1831199A1 Novel compounds |
| 09/12/2007 | EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 09/12/2007 | EP1830887A2 Antithrombotic dual inhibitors comprising a biotin residue |
| 09/12/2007 | EP1830875A2 Il-15 antigen arrays and uses thereof |
| 09/12/2007 | EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/12/2007 | EP1830852A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 09/12/2007 | EP1830830A2 Omega-3 fatty acids and dyslipidemic agent for lipid therapy |
| 09/12/2007 | EP1830826A2 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 09/12/2007 | EP1689447A4 Gene transfer for regulating smooth muscle tone |
| 09/12/2007 | EP1648475B1 Use of nitrite salts for the treatment of cardiovascular conditions |